(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one

Englisch Name:: (1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one

Synonyma:: PRC-2;Paricalcitol-1;Paligol impurity B;Paricalcitol Impurity 4;Paricalcitol Impurity 3;Paricalcitol Impurity A;Paricalcitol Intermediate-16;Paricalcitol Impurity 4 (PRC-2);<1R<1β(R*,E,S),3aα,7aβ>>-6-(Octahydro-7a-methyl-1H-4-oxoinden-1-yl)-2,3-dimethyl-4-hepten-2-ol;(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 55

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 55 Suche Produkte:

(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one Eigenschaften

25-HYDROXYVITAMIN D2

Global( 55)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49374	58
career henan chemical co	+86-0371-86658258 +8613203830695	factory@coreychem.com	China	29811	58
Neostar United (Changzhou) Industrial Co., Ltd.	+86-0519-85551759 +8613506123987	marketing1@neostarunited.com	China	8838	58
Shanxi Xuanran Import and Export Trade Co., Ltd.	+8617735180244	mike_yan@xuanranglobal.com	CHINA	4017	58
AFINE CHEMICALS LIMITED	+86-0571-85134551	sales@afinechem.com	China	15352	58
Hangzhou Huarong Pharm Co., Ltd.	571-86758373 +8613588754946	sales@huarongpharm.com	CHINA	3148	58
ShenZhen Trendseen Biological Technology Co.,Ltd.	13417589054	trendseenbio@gmail.com	China	11681	58
SUZHOU SENFEIDA CHEMICAL CO.,LTD	+86-0512-83500002 +8615195660023	sales@senfeida.com	China	23046	58

(1R,3aR,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-one
[1R-[1alpha,(1R*,2E,4S*),3abeta,7aalpha]]-Octahydro-1-(5-hydroxy-1,4,5-trimethyl-2-hexenyl)-7a-methyl-4H-inden-4-one
(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one
4H-Inden-4-one, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,7aR)-
1R-(1α(1R*,2E,4S*),3aβ,7aα)-octahydro-1-(5-hydroxy-1,4,5-triMethyl-2-hexen-yl)-7a-Methyl-4H-inden-4-one
Paricalcitol Impurity 4 (PRC-2)
(1R,3ar,7ar)-1-((2r,5s,e)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1h-inden-4(2h)-on
PRC-2
<1R<1β(R*,E,S),3aα,7aβ>>-6-(Octahydro-7a-methyl-1H-4-oxoinden-1-yl)-2,3-dimethyl-4-hepten-2-ol
Paricalcitol Impurity 3
Paricalcitol Impurity 4
(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
Paricalcitol Intermediate-16
Paricalcitol-1
Paricalcitol impurity 1/(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one
Paligol impurity B
Paricalcitol Impurity A
1R-(1α(1R*,2E,4S*),3aβ,7aα)-octahydro-1-(5-hydroxy-1,4,5-triMethyl-2-hexen-yl)-7a-Methyl-4H-inden-4-one
95716-68-0
Intermediates